May 02, 2024 / 08:30PM GMT
Operator
Hello, and welcome to veer biotechnologies First Quarter 2024 Financial Results and Business Update Call. As a reminder, this conference call is being recorded. (Operator Instructions) I will now turn the call over to Sasha Damouni Ellis, Executive Vice President Chief Corporate Affairs Officer.
Sasha Damouni Ellis - Vir Biotechnology Inc - Executive Vice President and Chief Corporate Affairs Officer
You may begin. Sasha Damouni Ellis, thank you and good afternoon. With me today are Dr. Marianne Bakker, Chief Executive Officer, Dr. Carey Blount, Senior Vice President, Clinical Research and interim Chief Medical Officer, and Sung Lee, Executive Vice President and Chief Financial Officer.
Before we begin, I would like to remind everyone that some of the statements we are making today are forward-looking statements under the securities laws. These forward-looking statements involve substantial risks and uncertainties that could cause our clinical development programs, future results, performance or achievements to differ significantly from those expressed
Q1 2024 Vir Biotechnology Inc Earnings Call Transcript
May 03, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers